Suryo Rahmanto Y - Search Results

1

The translational regulator eIF3a: the tricky eIF3 subunit!

Saletta F, Suryo Rahmanto Y, Richardson DR. Saletta F, et al. Among authors: suryo rahmanto y. Biochim Biophys Acta. 2010 Dec;1806(2):275-86. doi: 10.1016/j.bbcan.2010.07.005. Epub 2010 Jul 17. Biochim Biophys Acta. 2010. PMID: 20647036 Review.

2

Generation and characterization of transgenic mice hyper-expressing melanoma tumour antigen p97 (Melanotransferrin): no overt alteration in phenotype.

Suryo Rahmanto Y, Richardson DR. Suryo Rahmanto Y, et al. Biochim Biophys Acta. 2009 Jul;1793(7):1210-7. doi: 10.1016/j.bbamcr.2009.02.003. Epub 2009 Feb 24. Biochim Biophys Acta. 2009. PMID: 19245822 Free article.

3

Melanotransferrin: search for a function.

Suryo Rahmanto Y, Bal S, Loh KH, Yu Y, Richardson DR. Suryo Rahmanto Y, et al. Biochim Biophys Acta. 2012 Mar;1820(3):237-43. doi: 10.1016/j.bbagen.2011.09.003. Epub 2011 Sep 10. Biochim Biophys Acta. 2012. PMID: 21933697

4

N-myc downstream regulated 1 (NDRG1) is regulated by eukaryotic initiation factor 3a (eIF3a) during cellular stress caused by iron depletion.

Lane DJ, Saletta F, Suryo Rahmanto Y, Kovacevic Z, Richardson DR. Lane DJ, et al. Among authors: suryo rahmanto y. PLoS One. 2013;8(2):e57273. doi: 10.1371/journal.pone.0057273. Epub 2013 Feb 21. PLoS One. 2013. PMID: 23437357 Free PMC article.

5

The function of melanotransferrin: a role in melanoma cell proliferation and tumorigenesis.

Dunn LL, Sekyere EO, Suryo Rahmanto Y, Richardson DR. Dunn LL, et al. Among authors: suryo rahmanto y. Carcinogenesis. 2006 Nov;27(11):2157-69. doi: 10.1093/carcin/bgl045. Epub 2006 May 16. Carcinogenesis. 2006. PMID: 16704991

6

Identification of distinct changes in gene expression after modulation of melanoma tumor antigen p97 (melanotransferrin) in multiple models in vitro and in vivo.

Suryo Rahmanto Y, Dunn LL, Richardson DR. Suryo Rahmanto Y, et al. Carcinogenesis. 2007 Oct;28(10):2172-83. doi: 10.1093/carcin/bgm096. Epub 2007 Apr 21. Carcinogenesis. 2007. PMID: 17449903

7

The melanoma tumor antigen, melanotransferrin (p97): a 25-year hallmark--from iron metabolism to tumorigenesis.

Suryo Rahmanto Y, Dunn LL, Richardson DR. Suryo Rahmanto Y, et al. Oncogene. 2007 Sep 13;26(42):6113-24. doi: 10.1038/sj.onc.1210442. Epub 2007 Apr 23. Oncogene. 2007. PMID: 17452986 Review.

8

Bp44mT: an orally active iron chelator of the thiosemicarbazone class with potent anti-tumour efficacy.

Yu Y, Suryo Rahmanto Y, Richardson DR. Yu Y, et al. Among authors: suryo rahmanto y. Br J Pharmacol. 2012 Jan;165(1):148-66. doi: 10.1111/j.1476-5381.2011.01526.x. Br J Pharmacol. 2012. PMID: 21658021 Free PMC article.

9

Iron chelators for the treatment of cancer.

Yu Y, Gutierrez E, Kovacevic Z, Saletta F, Obeidy P, Suryo Rahmanto Y, Richardson DR. Yu Y, et al. Among authors: suryo rahmanto y. Curr Med Chem. 2012;19(17):2689-702. doi: 10.2174/092986712800609706. Curr Med Chem. 2012. PMID: 22455580 Review.

10

Differential regulation of the Menkes and Wilson disease copper transporters by hormones: an integrated model of metal transport in the placenta.

Richardson DR, Suryo Rahmanto Y. Richardson DR, et al. Among authors: suryo rahmanto y. Biochem J. 2007 Mar 1;402(2):e1-3. doi: 10.1042/BJ20061844. Biochem J. 2007. PMID: 17300224 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

38 results

Search Page